Centaurus Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,105
| Closed | -$107K | – | 761 |
|
|
2023
Q1 | $107K | Sell |
1,105
-100
| -8% | -$9.68K | 0.01% | 832 |
|
|
2022
Q4 | $125K | Sell |
1,205
-122
| -9% | -$12.7K | 0.01% | 720 |
|
|
2022
Q3 | $112K | Buy |
+1,327
| New | +$112K | 0.01% | 773 |
|
|
2022
Q1 | – | Sell |
-1,205
| Closed | -$106K | – | 894 |
|
|
2021
Q4 | $106K | Buy |
+1,205
| New | +$106K | 0.01% | 885 |
|
|
2020
Q1 | – | Sell |
-1,430
| Closed | -$121K | – | 531 |
|
|
2019
Q4 | $121K | Buy |
+1,430
| New | +$121K | 0.02% | 569 |
|
|
2019
Q3 | – | Sell |
-1,530
| Closed | -$131K | – | 463 |
|
|
2019
Q2 | $131K | Buy |
+1,530
| New | +$131K | 0.02% | 514 |
|
|
2018
Q3 | – | Sell |
-631
| Closed | -$59K | – | 707 |
|
|
2018
Q2 | $59K | Buy |
+631
| New | +$59K | 0.01% | 882 |
|